May 3, 2024, 2:44 PM
May 1, 2024, 11:04 AM
Amgen CEO Provides Promising Update on Experimental Weight Loss Drug
- Amgen's CEO gives an encouraging update on the experimental weight loss drug MariTide.
- Investors are eager for the Phase 2 trial data expected later this year.
- Amgen's move to focus on injection over a pill signals competition in the weight loss drug market.
Opinions
You've reached the end